Wed, Jun 19 · 9:00

In the context of ever-increasing drug potency, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds, enabling you to implement safe and robust practices in your own organization.

Incorporating insights from Genentech, Pfizer, Boehringer Ingelheim, SafeBridge and AbbVie, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly, safely and cost-effectively.

Brochure: https://go.evvnt.com/365662-3?pid=5731 

Prices:
Drug Developer Pricing - Early: USD 1399.0,
Drug Developer Pricing - Standard: USD 1799.0,
Solution Provider Pricing - Early: USD 2399.0,
Solution Provider Pricing - Standard: USD 2799.0

Speakers: David Eherts - Allergan, Andy Brewer - Genentech, John Roosa - Merck, Ben English - Nektar Therapeutics, Sarah Jones - Pfizer